MANAGEMENT
SEVERE (hypercalcemic crisis): 3.5-4 mol/L
NS IV bolus 30 ml / kg
Until BP and perfusion normalize
THEN
NS at 200-300 mL/h
Target U/O at 2 L / d
4 IU/kg intramuscular (IM) or subcutaneous (SC) q12h
MODERATE: 3-3.5 mmol/L:
IV FLUID:
NS IV bolus 30 ml / kg
Until BP and perfusion normalize
THEN
NS at 200-300 mL/h
Target U/O at 2 L / d
ASYMPTOMATIC / MILD: 2.63 mmol/L
Avoid potential causitive agents (eg, thiazides, vitamin D)
HYPERCALCEMIA OF MALIGNANCY:
Zoledronic acid 4 mg IV over 15 min or
Pamidronate 60-90 mg IV over 2-24 h
INVESTIGATIONS
Calcium
Pho
Mg
Albumin
Ionized Calcium
Creatinine
PTH
TSH
Lytes
ALP
Lipase (if abdominal pain)
CXR (consideration of malignancy)
CORRECTED CALCIUM
Measured total Ca (mmol/L) + 0.02(40- serum albumin [grams/L])
DOCUMENTATION
CLINICAL FEATURES
ASYMPTOMATIC
STONES (renal calculi, renal failure)
BONES (bone pain, arthralgia, osteoporosis)
ABDOMINAL GROANS (N/V, anorexia, abdominal pain, constipation, peptic ulcer disease, pancreatitis)
THRONES (polyuria / polydipsia, dehydration, nephrogenic DI))
PSYCHIATRIC OVERTONES (Lethargy, AMS, Hallucinations)
COMA
HISTORY
Ask about:
Known hypercalcemia
Parathyroid hormone
Malignancy
PHYSICAL EXAM
Mental Status
Neurologic
Volume Status
ECG
Shortened PR
Shortening QTc
Depressed ST segment
Widened T waves
SEVERITY
Mild: 2.6-3 mmol/L
Moderate: 3-3.5 mmol/L
Severe (hypercalcemic crisis): 3.5-4 mmol/L
CORRECTED CALCIUM
Measured total Ca (mmol/L) + 0.02(40- serum albumin [grams/L])
DDx
Primary Hyperparathyroidism
Hypercalcemia of Malignancy